Certified by Founder Lodge
S32
United States - Silicon Valley, CA
INVESTOR
1 Disclosed Funding Rounds $125,000,000
13 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
S32 is a venture capital firm investing at the frontiers of technology, healthcare and the life sciences with focus areas including biotechnology, therapeutics, advanced diagnostics, precisio
| Company | Date | Round | Raised |
|---|---|---|---|
 Endor Labs |
August, 04 ,2023 | Series A | $70,000,000 |
 Cohere |
February, 20 ,2022 | Series B | $125,000,000 |
 Function Oncology |
April, 13 ,2023 | Series A | $28,000,000 |
 Nusano |
October, 02 ,2024 | Series C | $115,000,000 |
 AltPep |
June, 26 ,2023 | Series B | $53,000,000 |
 Sola Security |
March, 14 ,2025 | Seed | $30,000,000 |
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 Character Biosciences |
March, 27 ,2025 | Series B | $39,000,000 |
| Endor Labs |
August, 04 ,2023 | Series A | $70,000,000 |
| Nusano |
October, 02 ,2024 | Series C | $115,000,000 |
| Sola Security |
March, 14 ,2025 | Seed | $30,000,000 |
| Character Biosciences |
March, 27 ,2025 | Series B | $39,000,000 |
 Infleqtion |
June, 03 ,2025 | Unknown | $100,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
